Cabergoline CAS No.: 81409-90-7
Dopamine Agonist for Veterinary Endocrine and Reproductive Management
Cabergoline is a potent dopamine D2-receptor agonist widely used to inhibit prolactin secretion. By stimulating dopamine receptors in the pituitary gland, cabergoline effectively suppresses prolactin release, helping regulate hormonal balance.
In veterinary medicine, cabergoline plays an important role in reproductive management and endocrine disorder treatment . Its targeted hormonal action makes it a valuable therapeutic option for managing prolactin-related conditions and supporting reproductive health across various animal species.
Mechanism of Action
Cabergoline acts by selectively activating dopamine D2 receptors , which inhibits prolactin synthesis and release from the pituitary gland. Reduced prolactin levels lead to:
▸ Decreased milk production
▸ Resolution of pseudo-pregnancy symptoms
▸ Improved hormonal balance
▸ Regulation of reproductive cycles
This mechanism allows precise control of prolactin-dependent physiological processes in animals.
Veterinary Applications
Inhibition of Prolactin Secretion
Cabergoline is commonly used to manage conditions caused by excess prolactin . In dogs and cats, elevated prolactin levels may result in:
▸ Mammary gland enlargement
Milk secretion
▸ Mastitis or mammary hyperplasia
Cabergoline effectively lowers prolactin levels, relieving these symptoms.
Treatment of Pseudopregnancy
Pseudopregnancy is frequently observed in female dogs and cats and is characterized by:
▸ Swollen mammary glands
▸ Lactation
▸ Nesting behavior or anxiety
Cabergoline alleviates these symptoms by suppressing prolactin secretion, helping restore normal physiological and behavioral states.
Reproductive Cycle Regulation
In certain species, such as horses, cabergoline is used to:
▸ Shorten reproductive anestrus or diapause
▸ Promote the return of normal estrous cycles
▸ Improve breeding efficiency
This makes it a valuable tool in controlled breeding programs.
Management of Pituitary Tumors
Cabergoline is used as part of the treatment strategy for pituitary tumors in animals. By inhibiting prolactin secretion, it helps manage:
▸ Hormonal imbalances
▸ Associated behavioral changes
▸ Clinical signs linked to endocrine dysfunction
Mammary Gland Disorders
In lactating animals such as cows and goats, cabergoline may be used to:
▸ Reduce milk production
▸ Relieve mammary congestion and inflammation
▸ Support treatment of mastitis and mammary hyperplasia
Behavioral Modulation
Abnormally high prolactin levels can contribute to behavioral issues such as anxiety, restlessness, or aggression. Cabergoline helps normalize behavior by restoring hormonal balance.
Key Benefits
▸ Potent and selective prolactin inhibition
▸ Effective management of pseudo-pregnancy
▸ Supports reproductive efficiency and hormonal control
▸ Useful in endocrine and pituitary-related disorders
▸ Helps manage mammary gland conditions
▸ Well-established role in veterinary medicine
Safety Considerations
Cabergoline should always be used under veterinary supervision . Proper dosing and monitoring are essential to minimize potential side effects and ensure animal safety and welfare.
Conclusion
Cabergoline (CAS No.: 81409-90-7) is a highly effective dopamine agonist with broad applications in veterinary endocrinology and reproductive management. Its ability to precisely regulate prolactin levels makes it an indispensable tool for treating pseudo-pregnancy, endocrine disorders, reproductive inefficiencies, and mammary gland conditions. When used responsibly, cabergoline significantly contributes to improved animal health and reproductive performance.
Hot Tags: cabergoline 81409-90-7, China cabergoline 81409-90-7 manufacturers, suppliers, factory, veterinary small molecular compounds for new drug development, Clorhidrato de Dexmedetomidina, Masitinib for veterinary, Small Molecular Compounds for Veterinary, small molecule agents for veterinary drug discovery, Robenacoxib CAS 220991 32 2







